Anthony Hoerning
Anthony A. Hoerning heads the Global Alliance Management, General Medicines, function within Business Development & Licensing (BD&L) at Novartis Pharma AG since November 2004; in this role, he is a member of the Board of Directors of the Association of Strategic Alliance Professionals (ASAP) since 2008. He has been a member of the Novartis Global BD&L management team for ten years, based in Basel, Switzerland. Prior to this, Mr. Hoerning was Novartis’ CFO in Brazil (1998-2000) and Head of Investor Relations and Capital Markets for the Novartis Group. In 1997, he was Chairman of the Swiss Investor Relations Society for a year. Before joining Novartis in 1993, Mr. Hörning was a VP with JPMorgan & Co., where he gained international capital markets experience with various types of client-related activities in Treasury, Credit, and Investment Banking in Zürich and New York. Mr. Hoerning graduated from Zürich University in 1983 with a Masters degree in Business Administration.
or